DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

Multiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

Welcome to the Journal of Nutrition Health & Aging, a prestigious publication dedicated to advancing knowledge in the critical fields of nutrition, gerontology, and geriatrics. Published by Elsevier Science Inc, this journal boasts an impressive impact factor and is recognized in the top quartile (Q1) of multiple categories including Geriatrics and Gerontology, Medicine (miscellaneous), and Nutrition and Dietetics. Since its inception in 1997, it has served as a vital platform for researchers, practitioners, and students alike to disseminate innovative research and practical applications relevant to aging populations. With a Scopus rank placing it in the top 15% of its field, it underscores its commitment to high-quality and impactful scholarship. Although it is not an open access journal, its significant reach ensures that valuable insights will continue to inform best practices and policy decisions in health and nutrition. We invite you to explore and contribute to this vital conversation surrounding health and well-being in older adults.

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.

Cancer Prevention Research, published by the American Association for Cancer Research, is a leading journal dedicated to advancing our understanding of cancer prevention strategies and their implementation in public health. With an ISSN of 1940-6207 and E-ISSN 1940-6215, this journal serves as a pivotal platform for researchers, healthcare professionals, and students who are committed to unraveling the complexities of cancer etiology and preventive measures. Since its inception in 2008, the journal has carved a niche in the scientific community, achieving notable rankings including Q2 in Cancer Research and Q1 in both Medicine (miscellaneous) and Oncology, highlighting its significance in disseminating influential research. Cancer Prevention Research is indexed in Scopus, reflecting a robust impact factor, and features a range of articles that address the preventive aspects of cancer to promote healthier populations. With access options available, it invites contributions that bridge laboratory findings with epidemiologic insights, making it an essential resource for anyone dedicated to reducing the burden of cancer globally.

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.